Literature DB >> 20619380

Exploiting knowledge of immune selection in HIV-1 to detect HIV-specific CD8 T-cell responses.

Coral-Ann M Almeida1, Steven G Roberts, Rebecca Laird, Elizabeth McKinnon, Imran Ahmad, Niamh M Keane, Abha Chopra, Carl Kadie, David Heckerman, Simon Mallal, Mina John.   

Abstract

Since HLA-restricted cytotoxic T-cell responses select specific polymorphisms in HIV-1 sequences and HLA diversity is relatively static in human populations, we investigated the use of peptide epitopes based on sites of HLA-associated adaptation in HIV-1 sequences to stimulate and detect T-cell responses ex vivo. These "HLA-optimised" peptides captured more HIV-1 Nef-specific responses compared with overlapping peptides of a single consensus sequence, in interferon-gamma enzyme linked immunospot assays. Sites of immune selection can reveal more immunogenic epitopes in HLA-diverse populations and offer insights into the nature of HLA-epitope targeting, which could be applied in vaccine design. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20619380      PMCID: PMC2949439          DOI: 10.1016/j.vaccine.2010.06.091

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  23 in total

1.  Comparison of the ELISPOT and cytokine flow cytometry assays for the enumeration of antigen-specific T cells.

Authors:  Annika C Karlsson; Jeffrey N Martin; Sophie R Younger; Barry M Bredt; Lorrie Epling; Rollie Ronquillo; Arjun Varma; Steven G Deeks; Joseph M McCune; Douglas F Nixon; Elizabeth Sinclair
Journal:  J Immunol Methods       Date:  2003-12       Impact factor: 2.303

2.  The Western Australian HIV Cohort Study, Perth, Australia.

Authors:  S A Mallal
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1998

3.  Peptide selection for human immunodeficiency virus type 1 CTL-based vaccine evaluation.

Authors:  Fusheng Li; Uma Malhotra; Peter B Gilbert; Natalie R Hawkins; Ann C Duerr; Juliana M McElrath; Lawrence Corey; Steven G Self
Journal:  Vaccine       Date:  2006-06-27       Impact factor: 3.641

4.  Identification of most frequent HLA class I antigen specificities in Botswana: relevance for HIV vaccine design.

Authors:  V Novitsky; P O Flores-Villanueva; P Chigwedere; S Gaolekwe; H Bussman; G Sebetso; R Marlink; E J Yunis; M Essex
Journal:  Hum Immunol       Date:  2001-02       Impact factor: 2.850

5.  Enhanced detection of human immunodeficiency virus type 1 (HIV-1) Nef-specific T cells recognizing multiple variants in early HIV-1 infection.

Authors:  Uma Malhotra; Fusheng Li; Jessica Nolin; Megan Allison; Hong Zhao; James I Mullins; Steve Self; M Juliana McElrath
Journal:  J Virol       Date:  2007-02-28       Impact factor: 5.103

6.  Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level.

Authors:  Corey B Moore; Mina John; Ian R James; Frank T Christiansen; Campbell S Witt; Simon A Mallal
Journal:  Science       Date:  2002-05-24       Impact factor: 47.728

7.  Comprehensive analysis of human immunodeficiency virus type 1-specific CD4 responses reveals marked immunodominance of gag and nef and the presence of broadly recognized peptides.

Authors:  Daniel E Kaufmann; Paul M Bailey; John Sidney; Bradford Wagner; Philip J Norris; Mary N Johnston; Lisa A Cosimi; Marylyn M Addo; Mathias Lichterfeld; Marcus Altfeld; Nicole Frahm; Christian Brander; Alessandro Sette; Bruce D Walker; Eric S Rosenberg
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

8.  Consistent cytotoxic-T-lymphocyte targeting of immunodominant regions in human immunodeficiency virus across multiple ethnicities.

Authors:  Nicole Frahm; B T Korber; C M Adams; J J Szinger; R Draenert; M M Addo; M E Feeney; K Yusim; K Sango; N V Brown; D SenGupta; A Piechocka-Trocha; T Simonis; F M Marincola; A G Wurcel; D R Stone; C J Russell; P Adolf; D Cohen; T Roach; A StJohn; A Khatri; K Davis; J Mullins; P J R Goulder; B D Walker; C Brander
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

9.  Enhanced detection of human immunodeficiency virus type 1-specific T-cell responses to highly variable regions by using peptides based on autologous virus sequences.

Authors:  Marcus Altfeld; Marylyn M Addo; Raj Shankarappa; Paul K Lee; Todd M Allen; Xu G Yu; Almas Rathod; Jason Harlow; Kristin O'Sullivan; Mary N Johnston; Philip J R Goulder; James I Mullins; Eric S Rosenberg; Christian Brander; Bette Korber; Bruce D Walker
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

10.  Precise identification of a human immunodeficiency virus type 1 antigen processing mutant.

Authors:  Peter Zimbwa; Anita Milicic; John Frater; Thomas J Scriba; Antony Willis; Philip J R Goulder; Tilly Pillay; Huldrych Gunthard; Jonathan N Weber; Hua-Tang Zhang; Rodney E Phillips
Journal:  J Virol       Date:  2006-11-15       Impact factor: 5.103

View more
  5 in total

Review 1.  Clinical and evolutionary consequences of HIV adaptation to HLA: implications for vaccine and cure.

Authors:  Santiago Avila-Rios; Jonathan M Carlson; Mina John; Simon Mallal; Zabrina L Brumme
Journal:  Curr Opin HIV AIDS       Date:  2019-05       Impact factor: 4.283

2.  Correlates of protective cellular immunity revealed by analysis of population-level immune escape pathways in HIV-1.

Authors:  Jonathan M Carlson; Chanson J Brumme; Eric Martin; Jennifer Listgarten; Mark A Brockman; Anh Q Le; Celia K S Chui; Laura A Cotton; David J H F Knapp; Sharon A Riddler; Richard Haubrich; George Nelson; Nico Pfeifer; Charles E Deziel; David Heckerman; Richard Apps; Mary Carrington; Simon Mallal; P Richard Harrigan; Mina John; Zabrina L Brumme
Journal:  J Virol       Date:  2012-10-10       Impact factor: 5.103

3.  Linking pig-tailed macaque major histocompatibility complex class I haplotypes and cytotoxic T lymphocyte escape mutations in simian immunodeficiency virus infection.

Authors:  Shayarana L Gooneratne; Hamid Alinejad-Rokny; Diako Ebrahimi; Patrick S Bohn; Roger W Wiseman; David H O'Connor; Miles P Davenport; Stephen J Kent
Journal:  J Virol       Date:  2014-10-01       Impact factor: 5.103

4.  Weaker HLA Footprints on HIV in the Unique and Highly Genetically Admixed Host Population of Mexico.

Authors:  Maribel Soto-Nava; Santiago Avila-Ríos; Humberto Valenzuela-Ponce; Claudia García-Morales; Jonathan M Carlson; Daniela Tapia-Trejo; Daniela Garrido-Rodriguez; Selma N Alva-Hernández; Thalía A García-Tellez; Akio Murakami-Ogasawara; Simon A Mallal; Mina John; Mark A Brockman; Chanson J Brumme; Zabrina L Brumme; Gustavo Reyes-Teran
Journal:  J Virol       Date:  2018-01-02       Impact factor: 5.103

5.  Autologous HIV-1 clade-B Nef peptides elicit increased frequency, breadth and function of CD8+ T-cells compared to consensus peptides.

Authors:  Mehrnoosh Doroudchi; Oleg Yegorov; Tom Baumgartner; Anne-Elen Kernaleguen; Gaelle Breton; Michel L Ndongala; Mohamed-Rachid Boulassel; Jean-Pierre Routy; Nicole F Bernard; Rafick-Pierre Sékaly; Bader Yassine-Diab
Journal:  PLoS One       Date:  2012-11-19       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.